Close Menu

HIV

The NextGen Group said this week its US subsidiary NextGen Sciences has signed a deal with the University of Nebraska for use of its csfdiscovery43 biomarker discovery assay.

By Monica Heger
This story, originally published Aug. 16, has been updated to clarify information about the performance of the company's tests.

A nucleic acid test marketed by Novartis Diagnostics and manufactured by Gen-Probe to screen individual blood donations for HIV and hepatitis have significantly increased the safety of the South African blood supply, according to recently presented data.

BGI, which, according to an official, generated roughly $6.2 million in proteomics revenue last year, plans to buy around 15 new high-resolution machines and 30 to 40 triple quadrupoles as part of its efforts to expand into the clinical proteomics and pharma markets.

BioMérieux’s NucliSens EasyQ MRSA test; Abbott's RealTime CMV assay; Roche's Cobas TaqScreen MPX Test v2.0; Idaho Tech's Q Fever molecular assay; Gen-Probe's Panther system.

Testing the ability of Roche's 454 GS FLX to detect viral tropism, researchers sequenced the viruses of 14 HIV patients, selecting specifically for the V3 loop of the virus, the region that allows it to infect human immune cells.

According to a paper published in Nature, miR-148a was found to regulate the expression of HLA-C, which plays a key role in immunity, with a variant having been associated with HIV load and progression to AIDS.

NIDA expects to provide $3 million next year for studies using systems biology approaches to explore links between HIV/AIDS and drug use and abuse.

The platform will combine immiscible phase filtration sample prep with automated amplification and detection, and is expected to have initial applications in point-of-care HIV testing in remote and resource-poor areas of the world. The company also sees the platform being used for decentralized molecular testing in more developed countries.

Pages

Following its departure from the European Union, the UK is to implement a fast-track visa program aimed at attracting scientific talent to Britain, according to BBC News.

ScienceInsider reports that researchers in Brazil are concerned that a creationist was chosen to run the agency that oversees graduate study programs there.

The Washington Post reports that researchers are quickly analyzing the coronavirus that has been causing illness and sharing their findings.

In PLOS this week: common variant associated with BMI in Arctic populations, analysis of microRNA markers associated with being born small for gestational age, and more.